Product
68Ga-DOTATOC
2 clinical trials
2 indications
Indication
Neuroendocrine TumorsClinical trial
An Open-label, Single Arm Clinical Trial of Gallium (68Ga) Edotreotide PET-CT Scan for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine TumorsStatus: Not yet recruiting, Estimated PCD: 2024-11-01
Clinical trial
Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT ScanStatus: Completed, Estimated PCD: 2017-03-01